Study on the correlation between Specialized pro-resolving Mediators (SPMs) and preeclampsia

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200057472

Enrollment

Unknown

Registered

2022-03-13

Start date

2022-04-01

Completion date

Unknown

Last updated

2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia

Interventions

Preeclampsia maternal group:None

Normal pregnancy group:None

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. 28-41 weeks of pregnancy; 3. Single pregnancy, fetal survival; 4. Voluntarily participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe fetal malformations/abnormalities (no heartbeat during Down's screening at 11-13 weeks of gestation); 2. Patients who routinely used aspirin before enrollment; 3. Severe mental disorder and inability to express wishes; 4. There are obvious other abnormal signs, laboratory tests and other clinical diseases, which are judged by the researcher to be unsuitable for the researcher; 5. The delivery information was not available to the researcher; 6. Patients who have a history of preeclampsia or eclampsia and have a normal pregnancy again.

Design outcomes

Primary

Measure	Time frame
Specialized pro-resolving mediators;	—

Countries

China

Contacts

Public ContactSong Xingrong

252110549@qq.com+86 18902268749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026